2004 Evolving Paradigms in the Treatment of Thoracic Malignancies

Friday, December 3, 2004
8:35 am - 9:50 am Session I: Prevention and Screening
Moderator: Karen Kelly
1. Chemoprevention Therapy - Karen Kelly
2. Combinatorial Chemoprevention of Lung Cancer - Scott Lippman
3. Early Detection - Kavita Garg
4. New Developments in Smoking Cessation: -Ellen Gritz

10:05 am - 11:05 am Session II: Diagnosis & Staging of NSCLC
Moderator: David Carbone
1. Role for IHC in NSCLC - Wilbur Franklin
2. Staging Tools in Lung Cancer - Edward Patz, Jr.
3. New Horizons in Proteomics Research and Staging - David Carbone

12:05 pm - 1:20 pm Session III: Management of Early-Stage NSCLC
Moderator: Katherine Pisters
1. Minimally Invasive Surgery - John Mitchell
2. Neoadjuvant Chemotherapy in Early-Stage NSCLC - Katherine Pisters
3. Adjuvant Therapy: What are the Issues and the Reality? - Giorgio Scagliotti & Larry Einhorn
4. New Options in Radiation Therapy - David Raben

1:20 am - 2:20 pm Session IV: Stage III NSCLC
Moderator: David Jablons
1. Chemoradiotherapy for Stage IIIA and Selected IIIB NSCLC -Howard West
2. Role of Surgery in Stage IIIA Disease and Selected IIIB - David Jablons

2:20 pm - 3:30 pm Session V: Advanced Disease
Moderator: Vincent Miller
1. First-Line Treatment in Advanced NSCLC - Mark Kris
2. Second-Line Treatment in Advanced NSCLC - Thomas Lynch
3. EGFR Inhibition in NSCLC and Treatment of BAC - Vincent Miller

7:00 am - 8:30 am Session VI: Advanced Disease
Moderator: Roy Herbst
1. Role of Anti-Angiogenic Agents - Roy Herbst
2. Neo-adjuvant Tissues Analysis - Roman Perez-Solar
3. Other Targeted Therapies in Stage IV NSCLC - Eric Rowinsky
4. Emerging Therapeutic Paradigms for Elderly and PS 2 NSCLC - Corey Langer
5. Clinical Trial Design - Chandra Belani

8:45 am - 10:00 am Session VII: Small Cell Lung Cancer
Moderator: Alan Sandler
1. Treatment of Limited - Extensive Stage SCLC - Alan Sandler
2. Chemotherapy Regimens for Recurrent SCLC - Janessa Laskin
3. Role of PCI in SCLC - Walter Curran, Jr.
4. Targeted Therapies in SCLC - Alex Adjei

10:00 am - 11:00 am Session VIII: Gender Issues in Lung Cancer
Moderator: Karen Kelly
1. Biological Differences - Joan Schiller
2. Clinical Differences - Kathy Albain

12:00 pm - 1:30 pm Session IX: Supportive Care
Moderator: Richard Gralla
1. Management of Anemia - Jennifer Garst
2. Simplifying the Management of Chemotherapy-Induced Neutropenia- Richard Gralla
3. Non-Platinum Doublets and Other Strategies to Minimize Chemotherapy Toxicities - Joseph Treat
4. Biphosphonates - Antoinette Wozniak

1:30 pm - 2:45 pm Session: X Mesothelioma
Moderator: Alan Sandler
1. Treatment of Unresectable Mesothelioma - Nicholas Vogelzang
2. Role of Surgery in Mesothelioma - W. Roy Smythe
3. Is there a Role for Neoadjuvant / Adjuvant Therapy in Mesothelioma? - Nicholas Vogelzang